๊ฑด๊ฐ• ๊ด€๋ฆฌ ์ˆ˜์ค€์ด ๋†’์•„์ง€๊ณ  ์ตœ์ ์˜ ๊ฑด๊ฐ• ์ƒํƒœ๋ฅผ ์œ ์ง€ํ•˜๋ ค๋Š” ์—ด๋ง์ด ์ปค์ง€๊ณ  ์›ฐ๋น™ ์ „๋ฐ˜์˜ ๊ด€์‹ฌ์ด ์ฆ๊ฐ€ํ•˜๋ฉด์„œ ์ „ ์„ธ๊ณ„ ์ธ๊ตฌ์˜ ํ‰๊ท  ์—ฐ๋ น์ด ๊ณ„์† ์˜ฌ๋ผ๊ฐ€๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์„ธ๊ณ„๋ณด๊ฑด๊ธฐ๊ตฌ(WHO)๋Š” 2050๋…„ ๋ฌด๋ ต์— ์ „ ์„ธ๊ณ„ 60์„ธ ์ด์ƒ ์ธ๊ตฌ๊ฐ€ ๋‘ ๋ฐฐ๋กœ ๋Š˜์–ด๋‚  ๊ฒƒ์œผ๋กœ ์ถ”์ •ํ•ฉ๋‹ˆ๋‹ค.

์˜ค๋ž˜ ์‚ฌ๋Š” ๊ฒƒ์€ ์ข‹์€ ์ผ์ด์ง€๋งŒ, ๋™์‹œ์— ๋งŒ์„ฑ ๋…ธํ™” ๊ด€๋ จ ์งˆํ™˜๋„ ์ฆ๊ฐ€ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์ด์ฒ˜๋Ÿผ ์ˆ˜๋ช…์ด ๋Š˜์–ด๋‚˜๋ฉด์„œ ๋งŽ์€ ์‚ฌ๋žŒ๋“ค์ด ๊ฑด๊ฐ•ํ•œ ๋…ธํ™”์— ๋„์›€์ด ๋˜๋Š” ๋ฐฉ๋ฒ•์€ ๋ฌด์—‡์ธ์ง€ ์ฐพ๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์ด๋ ‡๊ฒŒ ๊ฑด๊ฐ•ํ•œ ๋…ธํ™” ๋ฐฉ๋ฒ•์„ ์ฐพ๋Š” ๊ณผ์ •์—์„œ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๊ฐ€ ๋†’์€ ์ธ๊ธฐ๋ฅผ ์–ป๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋ž€ ๋ฌด์—‡์ผ๊นŒ์š”? ๊ฑด๊ฐ•ํ•œ ๋…ธํ™”์— ๋„์›€์„ ์ค„๊นŒ์š”? ๋„์›€์„ ์ค€๋‹ค๋ฉด ๊ทธ ๋ฐฉ์‹์€ ๋ฌด์—‡์ผ๊นŒ์š”?

์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋ž€ ๋ฌด์—‡์ธ๊ฐ€์š”?

'๋…ธํ™”๋œ ๊ฒƒ์„ ์ œ๊ฑฐํ•œ๋‹ค'๋Š” ๋œป์˜ ์„ธ๋†€๋ฆฌํ‹ฑ(senolytic)์ด๋ผ๋Š” ์šฉ์–ด๋Š” ์ตœ๊ทผ ๊ฑด๊ฐ•ํ•œ ๋…ธํ™”๋ฅผ ๋•๋Š” ํ™”ํ•ฉ๋ฌผ์˜ ์ง‘๋‹จ์„ ์ผ์ปซ๋Š” ๋ง์ด ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ๋”ฐ๋ผ์„œ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋Š” ๋…ธํ™” ๊ด€๋ จ ์งˆ๋ณ‘๊ณผ ์งˆํ™˜์˜ ๋ฐฉ์ง€๋‚˜ ์˜ˆ๋ฐฉ์— ์ผ๋ฐ˜์ ์œผ๋กœ ์‚ฌ์šฉ๋˜๋Š” ์˜์–‘์ด ํ’๋ถ€ํ•œ ๋ฌผ์งˆ์„ ๋œปํ•ฉ๋‹ˆ๋‹ค.

์ฅ๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์‹ค์‹œํ•œ ์—ฐ๊ตฌ์—์„œ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋Š” ์ˆ˜๋ช… ์—ฐ์žฅ์—๋„ ๋„์›€์ด ๋  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

๋Œ€๋ถ€๋ถ„์˜ ์—ฐ๊ตฌ์—์„œ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋Š” ๋‹ค์–‘ํ•œ ๋ฐฉ์‹์œผ๋กœ ์ž‘์šฉํ•œ๋‹ค๋Š” ์ ์„ ์ œ์‹œํ•ฉ๋‹ˆ๋‹ค. ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ์˜ ์ฃผ์š” ์ž‘์šฉ ๋ฐฉ์‹ ์ค‘ ํ•˜๋‚˜๋Š” ๋…ธํ™” ์„ธํฌ๋ฅผ ํ‘œ์ ์œผ๋กœ ์‚ผ๋Š” ๊ฒƒ์ž…๋‹ˆ๋‹ค. ๋…ธํ™” ์„ธํฌ๋Š” ์‹ ์ฒด์—์„œ ๋” ์ด์ƒ ์ œ๋Œ€๋กœ ๊ธฐ๋Šฅํ•˜์ง€ ์•Š๋Š” ์˜ค๋ž˜๋˜๊ฑฐ๋‚˜ ๋Š™์€ ์„ธํฌ์ž…๋‹ˆ๋‹ค.

์„ธํฌ๋Š” ์„ธํฌ ์†์ƒ, ์•” ์ด‰์ง„ ์œ ์ „์ž, ๋””์˜ฅ์‹œ๋ฆฌ๋ณดํ•ต์‚ฐ(DNA) ์†์ƒ, ํ…”๋กœ๋ฏธ์–ด ๋‹จ์ถ• ๋“ฑ์œผ๋กœ ์ธํ•ด ๋…ธํ™” ์„ธํฌ๊ฐ€ ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

์‹ ์ฒด๊ฐ€ ๋Š™์œผ๋ฉด์„œ ๋…ธํ™” ์„ธํฌ๊ฐ€ ์ฒด๋‚ด์— ์ถ•์ ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์„ธํฌ๋Š” ๋” ์ด์ƒ ์ฆ์‹ํ•˜์ง€ ์•Š์œผ๋ฉด์„œ ์„ธํฌ ์‚ฌ๋ฉธ์—๋„ ์ €ํ•ญํ•ฉ๋‹ˆ๋‹ค. ๋…ธํ™” ์„ธํฌ๋Š” ์ฃฝ๋Š” ์ˆ˜์ˆœ์„ ๋ฐŸ๋Š” ๊ฒƒ์ด ์ž์—ฐ์Šค๋Ÿฌ์šด ํ˜„์ƒ์ด๋ฉฐ, ์ด๋ฅผ ์„ธํฌ ์‚ฌ๋ฉธ์ด๋ผ๊ณ  ํ•ฉ๋‹ˆ๋‹ค. ์„ธํฌ ์‚ฌ๋ฉธ์ด ์ผ์–ด๋‚˜์•ผ ์ƒˆ๋กœ์šด ์„ธํฌ๊ฐ€ ๋…ธํ™” ์„ธํฌ๋ฅผ ๋Œ€์ฒดํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๋…ธํ™” ์„ธํฌ ๋˜๋Š” '์ข€๋น„' ์„ธํฌ๊ฐ€ ์ฃฝ๊ธฐ๋ฅผ ๊ฑฐ๋ถ€ํ•˜๋ฉด ์—ผ์ฆ, ์กฐ์ง ์†์ƒ, ๋งŒ์„ฑ ์งˆํ™˜, ์งˆ๋ณ‘์˜ ์ฆ๊ฐ€๋ฅผ ์œ ๋ฐœํ•˜๋Š” ์œ ํ•ด ๋‹จ๋ฐฑ์งˆ์„ ๋ถ„๋น„ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ์ผ๋ถ€ ์—ฐ๊ตฌ์—์„œ๋Š” ๋‹ค์–‘ํ•œ ์งˆ๋ณ‘์ด ๋…ธํ™” ์„ธํฌ์˜ ์ถ•์ ์œผ๋กœ ์ธํ•ด ๋ฐœ์ƒํ•œ๋‹ค๊ณ  ์ง€์ ํ•ฉ๋‹ˆ๋‹ค. ์‹ฌํ˜ˆ๊ด€ ์งˆํ™˜, ๋Œ€์‚ฌ ๊ธฐ๋Šฅ ์žฅ์• , ์‹ ์žฅ ์งˆํ™˜, ์•”, ์‹ฌ์ง€์–ด ๋…ธํ™”๋กœ ์ธํ•œ ์‡ ์•ฝ ๋“ฑ์˜ ์งˆ๋ณ‘์ด ๋…ธํ™”๋œ '์ข€๋น„' ์„ธํฌ์™€ ๊ด€๋ จ์ด ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋ณด์ž…๋‹ˆ๋‹ค. ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๊ฐ€ ๋…ธํ™” ์„ธํฌ๋ฅผ ์ค„์ด๋Š” ๋ฐ ๋„์›€์ด ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ฑด๊ฐ•ํ•œ ๋…ธํ™”๋ฅผ ๋•๋Š” 6๊ฐ€์ง€ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋ฅผ ์†Œ๊ฐœํ•˜๊ฒ ์Šต๋‹ˆ๋‹ค.

1. ํ”ผ์„ธํ‹ด

ํ”ผ์„ธํ‹ด์€ ๊ฐ€์žฅ ๊ฐ•๋ ฅํ•œ ํšจ๊ณผ๋ฅผ ๋ฐœํœ˜ํ•˜๋Š” ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ์— ์†ํ•ฉ๋‹ˆ๋‹ค. ํ”ผ์„ธํ‹ด์€ ์ž์—ฐ์ ์œผ๋กœ ์กด์žฌํ•˜๋Š” ๋ถ„์ž์ธ ํ”Œ๋ผ๋ณด๋…ธ์ด๋“œ๋กœ ๋‹ค์–‘ํ•œ ๊ณผ์ผ๊ณผ ์ฑ„์†Œ์— ํ•จ์œ ๋˜์–ด ์žˆ์Šต๋‹ˆ๋‹ค.

ํ”ผ์„ธํ‹ด ํ•จ๋Ÿ‰์ด ๋†’์€ ์‹ํ’ˆ์œผ๋กœ๋Š” ๋”ธ๊ธฐ, ์‚ฌ๊ณผ, ํ† ๋งˆํ† , ์˜ค์ด ๋“ฑ์ด ์žˆ์Šต๋‹ˆ๋‹ค.

์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ํ”ผ์„ธํ‹ด์€ ๊ฐ•๋ ฅํ•œ ์„ธ๋†€๋ฆฌํ‹ฑ ์ž‘์šฉ์„ ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•œ ์‹œํ—˜๊ด€ ์—ฐ๊ตฌ์—์„œ๋Š” ์‚ฌ๋žŒ์˜ ์ง€๋ฐฉ ์กฐ์ง์„ ์‚ฌ์šฉํ•˜์—ฌ ํ”ผ์„ธํ‹ด์˜ ์„ธ๋†€๋ฆฌํ‹ฑ ํšจ๊ณผ๋ฅผ ์‹œํ—˜ํ–ˆ์Šต๋‹ˆ๋‹ค. ์ด ์—ฐ๊ตฌ์—์„œ ํ”ผ์„ธํ‹ด์ด ์ธ์ฒด ์ง€๋ฐฉ ์กฐ์ง์—์„œ ์ข€๋น„๋‚˜ ๋‹ค๋ฆ„ ์—†๋Š” ๋…ธํ™” ์„ธํฌ๋ฅผ ์ œ๊ฑฐํ•  ์ˆ˜ ์žˆ์—ˆ์œผ๋ฉฐ, ๊ทธ ๊ฒฐ๊ณผ ์ „๋ฐ˜์ ์œผ๋กœ ๋…ธํ™” ์„ธํฌ๊ฐ€ ๊ฐ์†Œํ–ˆ๋‹ค๋Š” ์‚ฌ์‹ค์ด ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค.

์ด์–ด์„œ ์ด ์—ฐ๊ตฌ์—์„œ๋Š” ๋…ธํ™”๋œ ์ฅ๋ฅผ ๋Œ€์ƒ์œผ๋กœ ํ”ผ์„ธํ‹ด์˜ ํšจ๊ณผ๋ฅผ ์‹œํ—˜ํ–ˆ์Šต๋‹ˆ๋‹ค. ์—ฐ๊ตฌ ๊ฒฐ๊ณผ, ํ”ผ์„ธํ‹ด์„ ๋ณด์ถฉํ•˜๋ฉด ์ฅ์˜ ์ˆ˜๋ช…์ด ์—ฐ์žฅ๋˜๋Š” ๋™์‹œ์— ์žฅ๊ธฐ๊ฐ€ ๋‚ด๋ถ€ ๊ท ํ˜•์„ ๋˜์ฐพ๊ณ  ๋…ธํ™” ๊ด€๋ จ ์งˆ๋ณ‘์ด ์ค„์–ด๋“ค ์ˆ˜ ์žˆ๋‹ค๋Š” ๊ฒฐ๋ก ์„ ๋‚ด๋ ธ์Šต๋‹ˆ๋‹ค.

์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ํ”ผ์„ธํ‹ด์€ ํ•ญ์—ผ์ฆ ์ž‘์šฉ๋„ ํ•ฉ๋‹ˆ๋‹ค. ํ•œ ์‹œํ—˜๊ด€ ์—ฐ๊ตฌ์—์„œ ํ”ผ์„ธํ‹ด์€ ์—ผ์ฆ์„ฑ ์‚ฌ์ดํ† ์นด์ธ(์„ธํฌ ์‹ ํ˜ธ์ „๋‹ฌ๋ฌผ์งˆ)์˜ ๋ถ„๋น„๋ฅผ ๋ง‰๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค.

ํ”ผ์„ธํ‹ด์€ ๊ฐ•๋ ฅํ•œ ํ•ญ์—ผ์ฆ ์ž‘์šฉ์„ ํ•˜๊ณ  ์ข€๋น„ ์„ธํฌ๋ฅผ ์ค„์ด๋Š” ํšจ๋Šฅ์œผ๋กœ ๊ฑด๊ฐ•ํ•œ ๋…ธํ™” ์ง€์›์— ํฐ ํž˜์„ ๋ฐœํœ˜ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

2. ์•„ํ”ผ์ œ๋‹Œ

์•„ํ”ผ์ œ๋‹Œ์€ ํ”ผ์„ธํ‹ด๊ณผ ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ ํŒŒ์Šฌ๋ฆฌ, ์…€๋Ÿฌ๋ฆฌ, ์•„ํ‹ฐ์ดˆํฌ, ์นด๋ชจ๋งˆ์ผ ๋“ฑ์˜ ์‹ํ’ˆ์— ์ž์—ฐ์ ์œผ๋กœ ์กด์žฌํ•˜๋Š” ํ”Œ๋ผ๋ณด๋…ธ์ด๋“œ์ž…๋‹ˆ๋‹ค.

์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ์•„ํ”ผ์ œ๋‹Œ์€ ๊ฐ•๋ ฅํ•œ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ์ผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํ•œ ์‹œํ—˜๊ด€ ์—ฐ๊ตฌ์—์„œ ์•„ํ”ผ์ œ๋‹Œ์€ ๋…ธํ™” ์„ธํฌ์˜ ์œ ํ•ดํ•œ ๋‹จ๋ฐฑ์งˆ ๋ถ„๋น„๋ฅผ ๋ง‰์„ ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค.

๋…ธํ™” ์„ธํฌ๊ฐ€ ๋ถ„๋น„ํ•˜๋Š” ํ•ด๋กœ์šด ๋‹จ๋ฐฑ์งˆ์€ ๋‹จ์ˆœํžˆ ์—ผ์ฆ์„ ์ฆ๊ฐ€์‹œํ‚ค๋Š” ๋ฐ ๊ทธ์น˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ๋…ธํ™” ์„ธํฌ์—์„œ ๋ถ„๋น„๋˜๋Š” ๋‹จ๋ฐฑ์งˆ์€ ๊ฑด๊ฐ•ํ•œ ์„ธํฌ๋ฅผ ์ข€๋น„ ์„ธํฌ๋กœ ์ „ํ™˜์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค๋Š” ์‚ฌ์‹ค์ด ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ๋กœ ๋“œ๋Ÿฌ๋‚ฌ์Šต๋‹ˆ๋‹ค.

๋˜ํ•œ ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ์•„ํ”ผ์ œ๋‹Œ์€ ์‹ ์ฒด์—์„œ ๊ธ€๋ฃจํƒ€์น˜์˜จ์ด ๋งŽ์ด ์ƒ์„ฑ๋˜๋„๋ก ๋•๋Š” ๊ฐ•๋ ฅํ•œ ํ•ญ์‚ฐํ™”์ œ์ž…๋‹ˆ๋‹ค.

๊ธ€๋ฃจํƒ€์น˜์˜จ์€ ํ”ํžˆ ์‹ ์ฒด์˜ ์ตœ๊ณ  ํ•ญ์‚ฐํ™”์ œ๋กœ ์ธ์ •๋ฐ›์Šต๋‹ˆ๋‹ค. ๊ธ€๋ฃจํƒ€์น˜์˜จ์€ ์‚ฐํ™” ์ŠคํŠธ๋ ˆ์Šค๋กœ๋ถ€ํ„ฐ ์„ธํฌ๋ฅผ ๋ณดํ˜ธํ•˜๋Š” ๋ฐ ํ•„์ˆ˜์ ์ธ ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ์•ฝ๋ฌผ๊ณผ ๊ฐ™์€ ์™ธ๋ถ€ ๋ฌผ์งˆ๋กœ ์ธํ•ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋Š” ๋…์„ฑ์œผ๋กœ๋ถ€ํ„ฐ ์„ธํฌ๋ฅผ ๋ณดํ˜ธํ•˜๋Š” ๋ฐ ๋„์›€์„ ์ค๋‹ˆ๋‹ค.

์‹ ์ฒด๊ฐ€ ๋Š™์–ด๊ฐ€๋ฉด์„œ ๊ธ€๋ฃจํƒ€์น˜์˜จ์˜ ์ƒ์„ฑ๋Ÿ‰์ด ๊ฐ์†Œํ•˜๋ฏ€๋กœ ์‚ฐํ™” ์ŠคํŠธ๋ ˆ์Šค๊ฐ€ ์ฆ๊ฐ€ํ•  ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ์Šต๋‹ˆ๋‹ค.

3. ํ€˜๋ฅด์„ธํ‹ด

ํ€˜๋ฅด์„ธํ‹ด๋„ ๊ฐ•๋ ฅํ•œ ํšจ๊ณผ๋ฅผ ๋ฐœํœ˜ํ•˜๋Š” ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ์ž…๋‹ˆ๋‹ค. ํ”ผ์„ธํ‹ด์ด๋‚˜ ์•„ํ”ผ์ œ๋‹Œ๊ณผ ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ, ํ€˜๋ฅด์„ธํ‹ด๋„ ์ž์—ฐ์ ์œผ๋กœ ์กด์žฌํ•˜๋Š” ํ”Œ๋ผ๋ณด๋…ธ์ด๋“œ์ž…๋‹ˆ๋‹ค. ํ€˜๋ฅด์„ธํ‹ด์ด ํ•จ์œ ๋œ ์‹ํ’ˆ์œผ๋กœ๋Š” ์–‘ํŒŒ, ๋ธŒ๋กœ์ฝœ๋ฆฌ, ์‚ฌ๊ณผ, ์ฒด๋ฆฌ ๋“ฑ์ด ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•œ ์˜คํ”ˆ ๋ผ๋ฒจ 1์ƒ ์„ ํ–‰ ์—ฐ๊ตฌ์—์„œ๋Š” ๋‹น๋‡จ๋ณ‘์œผ๋กœ ์ธํ•ด ์‹ ์žฅ ์งˆํ™˜ ์ง„๋‹จ์„ ๋ฐ›์€ 9๋ช…์˜ ์ฐธ๊ฐ€์ž๋ฅผ ๋Œ€์ƒ์œผ๋กœ ํ€˜๋ฅด์„ธํ‹ด๊ณผ ์˜์•ฝํ’ˆ์˜ ํšจ๊ณผ๋ฅผ ์ถ”์  ๊ด€์ฐฐํ–ˆ์Šต๋‹ˆ๋‹ค.

์ด๋“ค ์ฐธ๊ฐ€์ž 9๋ช…์€ ๋‚จ์„ฑ๊ณผ ์—ฌ์„ฑ์œผ๋กœ ๊ตฌ์„ฑ๋˜์—ˆ์œผ๋ฉฐ ์—ฐ๋ น๋Œ€๋Š” 68~71์„ธ์˜€์Šต๋‹ˆ๋‹ค. ์ด ์—ฐ๊ตฌ์—์„œ๋Š” ์ฐธ๊ฐ€์ž๋“ค์—๊ฒŒ 3์ผ ๋™์•ˆ ํ€˜๋ฅด์„ธํ‹ด๊ณผ ๋‹ค์‚ฌํ‹ฐ๋‹™(dasatinib) ์•ฝ๋ฌผ์„ ํˆฌ์—ฌํ•˜๊ณ  11์ผ ๊ฐ„๊ฒฉ์œผ๋กœ ์ง€๋ฐฉ ์กฐ์ง ๋‚ด ๋…ธํ™” ์„ธํฌ์˜ ์–‘์„ ์ธก์ •ํ–ˆ์Šต๋‹ˆ๋‹ค.

์—ฐ๊ตฌ ๊ฒฐ๊ณผ, ํ€˜๋ฅด์„ธํ‹ด๊ณผ ์•ฝ๋ฌผ์˜ ๋ณ‘ํ–‰ ํˆฌ์—ฌ๋กœ ์ง€๋ฐฉ ์กฐ์ง ๋‚ด ๋…ธํ™” ์„ธํฌ ์ˆ˜๊ฐ€ ํฌ๊ฒŒ ๊ฐ์†Œํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ์—ฐ๊ตฌํŒ€์€ ํ€˜๋ฅด์„ธํ‹ด๊ณผ ์•ฝ๋ฌผ์˜ ์กฐํ•ฉ์ด ์—ผ์ฆ์„ฑ ์„ธํฌ ์‹ ํ˜ธ์ „๋‹ฌ๋ฌผ์งˆ์˜ ๋ถ„๋น„๋ฅผ ์ค„์ด๋Š” ํ•ญ์—ผ์ฆ ์ž‘์šฉ์„ ํ•œ๋‹ค๋Š” ์‚ฌ์‹ค๋„ ๋ฐํ˜€๋ƒˆ์Šต๋‹ˆ๋‹ค.

ํ•œ ๊ฒ€ํ†  ์—ฐ๊ตฌ์—์„œ๋Š” ํ€˜๋ฅด์„ธํ‹ด ๋ณด์ถฉ์ œ๊ฐ€ ๋…ธํ™” ๊ด€๋ จ ์‹ฌ๋ถ€์ „์„ ์˜ˆ๋ฐฉํ•˜๋Š” ์‹ฌ์žฅ ๋ณดํ˜ธ ์—ญํ• ์„ ํ•  ์ˆ˜๋„ ์žˆ๋‹ค๊ณ  ๋ฐํ˜”์Šต๋‹ˆ๋‹ค.

4. ์ปคํ๋ฏผ

์ปคํ๋ฏผ์€ ํ™ฉ๊ธˆ๋น› ํ–ฅ์‹ ๋ฃŒ์ธ ๊ฐ•ํ™ฉ์— ํ•จ์œ ๋œ ์„ฑ๋ถ„์œผ๋กœ ์ƒ๋ฌผํ•™์ ์œผ๋กœ ํ™œ์„ฑ์„ ๋ ๋Š” ์ฃผ์š” ํ™”ํ•ฉ๋ฌผ์ž…๋‹ˆ๋‹ค. ์ตœ๊ทผ ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์—์„œ ์ปคํ๋ฏผ์€ ๊ฐ•๋ ฅํ•œ ํ•ญ์—ผ์ฆ ์—ญํ• ๋ถ€ํ„ฐ ํ•ญ์•” ์ž‘์šฉ๊นŒ์ง€ ๋‹ค์–‘ํ•œ ๊ฑด๊ฐ• ์ฆ์ง„ ํšจ๋Šฅ์ด ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

์ปคํ๋ฏผ์ด ๋…ธํ™” ์„ธํฌ๋ฅผ ์ œ๊ฑฐํ•˜๋Š” ๋†€๋ผ์šด ๋ฌผ์งˆ์ผ ์ˆ˜ ์žˆ๋‹ค๋Š” ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋„ ๋ฐœํ‘œ๋˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์—ฌ๋Ÿฌ ๋™๋ฌผ ์—ฐ๊ตฌ์—์„œ ์ปคํ๋ฏผ์€ ํ•ญ์‚ฐํ™” ํšจ๋Šฅ์„ ๋ฐœํœ˜ํ•˜์—ฌ ์ˆ˜๋ช… ์—ฐ์žฅ์— ๊ธฐ์—ฌํ•  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋“œ๋Ÿฌ๋‚ฌ์Šต๋‹ˆ๋‹ค.

ํ•œ ๋™๋ฌผ ์—ฐ๊ตฌ์—์„œ๋Š” ์ปคํ๋ฏผ์„ ๋ณด์ถฉํ•œ ์œ„์Šคํƒ€ ์ฅ์˜ ๊ฒฝ์šฐ ํ‰๊ท  ์ˆ˜๋ช…์ด ๊ฑฐ์˜ 40%๊นŒ์ง€ ์ฆ๊ฐ€ํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

ํšŒ์ถฉ์ธ ์บ๋…ธํ–…๋””ํ‹ฐ์Šค ์—˜๋ ˆ๊ฐ„์Šค(Caenorhabditis elegans)๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์‹ค์‹œํ•œ ๋‹ค๋ฅธ ํ•œ ๋™๋ฌผ ์—ฐ๊ตฌ์—์„œ๋Š” ์ปคํ๋ฏผ ๋ณด์ถฉ์ด ์ตœ๋Œ€ ์ˆ˜๋ช…์„ 20% ์ด์ƒ ๋Š˜๋ฆฐ๋‹ค๋Š” ์‚ฌ์‹ค์ด ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค. C. ์—˜๋ ˆ๊ฐ„์Šค์˜ ์ˆ˜๋ช…์€ ๋ณดํ†ต 12~18์ผ ์ •๋„์ž…๋‹ˆ๋‹ค. ์ด ์—ฐ๊ตฌ์—์„œ๋Š” ์ปคํ๋ฏผ ๋ณด์ถฉ์œผ๋กœ ํšŒ์ถฉ์˜ ์ˆ˜๋ช…์ด 3์ผ ์ด์ƒ ์—ฐ์žฅ๋  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

์ปคํ๋ฏผ์€ ๊ฑด๊ฐ•ํ•œ ํ…”๋กœ๋ฏธ์–ด ๊ธธ์ด์— ๋„์›€์„ ์ฃผ๋Š” ํšจ์†Œ์˜ ํ™œ์„ฑ์„ ๋†’์—ฌ ์ˆ˜๋ช…์„ ๋Š˜๋ฆด ์ˆ˜ ์žˆ๋‹ค๋Š” ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๊ฐ€ ์žˆ์Šต๋‹ˆ๋‹ค. ํ…”๋กœ๋ฏธ์–ด๋Š” DNA์˜ ๋ง๋‹จ ๋ถ€์œ„์ž…๋‹ˆ๋‹ค. ํ…”๋กœ๋ฏธ์–ด๋Š” ๋‚˜์ด๊ฐ€ ๋“ค์ˆ˜๋ก ์งง์•„์ง‘๋‹ˆ๋‹ค.

ํ…”๋กœ๋ฏธ์–ด ๊ธธ์ด๊ฐ€ ์งง์•„์ง€๋ฉด ๋…ธํ™” ๊ด€๋ จ ์งˆ๋ณ‘์ด ์ฆ๊ฐ€ํ•˜๊ณ  ์ˆ˜๋ช…์ด ๋‹จ์ถ•๋˜๋Š” ๊ฒƒ์œผ๋กœ ๋ณด์ž…๋‹ˆ๋‹ค.

5. ๋ฐ€ํฌ์‹œ์Šฌ

ํ”ํžˆ ๋ฐ€ํฌ์‹œ์Šฌ์ด๋ผ๊ณ  ์•Œ๋ ค์ง„ ์‹ค๋ฆฌ๋ฒ” ๋งˆ๋ฆฌ์•„๋„˜(Silybum marianum)์€ ๊ฐ•๋ ฅํ•œ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋กœ ํšจ๊ณผ๋ฅผ ๋ฐœํœ˜ํ•  ์ˆ˜ ์žˆ๋Š” ์œ ๋งํ•œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์—ฌ์ฃผ๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ๋ฐ€ํฌ์‹œ์Šฌ์€ ๊ตญํ™”๊ณผ์— ์†ํ•˜๋Š” ํ—ˆ๋ธŒ์ž…๋‹ˆ๋‹ค. ์ง€์ค‘ํ•ด๊ฐ€ ์›์‚ฐ์ง€์ธ ๋ฐ€ํฌ์‹œ์Šฌ์€ ํ˜„์žฌ ์ „ ์„ธ๊ณ„์ ์œผ๋กœ ์„ญ์ทจํ•˜๋Š” ํ—ˆ๋ธŒ์ž…๋‹ˆ๋‹ค.

์ด ํŠน๋ณ„ํ•œ ํ—ˆ๋ธŒ๋Š” ๊ฐ„๊ณผ ๋‹ด๋‚ญ ๊ฑด๊ฐ•์„ ์œ„ํ•ด ์„ญ์ทจํ•˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์ง€๋งŒ, ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋กœ๋„ ์—ญํ• ์„ ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํ•œ ์‹œํ—˜๊ด€ ์—ฐ๊ตฌ์—์„œ๋Š” ๋…ธํ™”๊ฐ€ ์ง„ํ–‰๋œ ์‚ฌ๋žŒ์˜ ํ”ผ๋ถ€ ์„ธํฌ์— ๋ฐ€ํฌ์‹œ์Šฌ ์ถ”์ถœ๋ฌผ์„ ์‚ฌ์šฉํ–ˆ์Šต๋‹ˆ๋‹ค.

์ด ์—ฐ๊ตฌ์—์„œ๋Š” ๋…ธํ™”๋œ ํ”ผ๋ถ€ ์„ธํฌ๊ฐ€ ์ Š์€ ํ”ผ๋ถ€ ์„ธํฌ์˜ ์„ฑ์žฅ๊ณผ ์ฆ์‹์„ ๊ฐ€๋กœ๋ง‰๋Š”๋‹ค๊ณ  ์ง€์ ํ–ˆ์Šต๋‹ˆ๋‹ค. ๋˜ํ•œ ๋…ธํ™” ์„ธํฌ๋Š” ์ •์ƒ ํ”ผ๋ถ€ ์„ธํฌ๋ฅผ ์ข€๋น„ ๊ฐ™์€ ์ƒํƒœ๋กœ ๋งŒ๋“ค์—ˆ์Šต๋‹ˆ๋‹ค.

์ด ์—ฐ๊ตฌ์—์„œ ๋ฐ€ํฌ์‹œ์Šฌ ์ถ”์ถœ๋ฌผ์ด ๋…ธํ™” ํ”ผ๋ถ€ ์„ธํฌ๋ฅผ ์ œ๊ฑฐํ•˜๊ณ  ์ Š์€ ํ”ผ๋ถ€ ์„ธํฌ์˜ ์ฆ์‹์„ ์ด‰์ง„ํ•  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค. ์—ฐ๊ตฌํŒ€์€ ๋ฐ€ํฌ์‹œ์Šฌ์ด ํ”ผ๋ถ€ ์„ธํฌ๋ฅผ ์ Š์–ด์ง€๊ฒŒ ํ•˜๊ณ  ์กฐ๊ธฐ ๋…ธํ™”๋ฅผ ๋ฐฉ์ง€ํ•  ์ˆ˜ ์žˆ๋‹ค๋Š” ๊ฒฐ๋ก ์„ ๋‚ด๋ ธ์Šต๋‹ˆ๋‹ค.

๋ฐ€ํฌ์‹œ์Šฌ์€ ์ž ์žฌ์ ์ธ ์„ธ๋†€๋ฆฌํ‹ฑ ํšจ๋Šฅ ์™ธ์—๋„ ์‹ ์ง„๋Œ€์‚ฌ ์ง€์›๋ถ€ํ„ฐ ๊ฑด๊ฐ•ํ•œ ํ˜ˆ์•• ์œ ์ง€๊นŒ์ง€ ๋‹ค์–‘ํ•œ ํšจ๋Šฅ์„ ๋ฐœํœ˜ํ•˜๋Š” ๋†€๋ผ์šด ํ•ญ์‚ฐํ™”์ œ์ผ ์ˆ˜ ์žˆ๋‹ค๋Š” ์‚ฌ์‹ค์ด ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์—์„œ ๋“œ๋Ÿฌ๋‚ฌ์Šต๋‹ˆ๋‹ค.

6. ์—ํ”ผ๊ฐˆ๋กœ์นดํ…Œํ‚จ ๊ฐˆ๋ ˆ์ดํŠธ(EGCG)

EGCG๋กœ ์•Œ๋ ค์ง„ ์—ํ”ผ๊ฐˆ๋กœ์นดํ…Œํ‚จ ๊ฐˆ๋ ˆ์ดํŠธ๊ฐ€ ๊ฑด๊ฐ•ํ•œ ๋…ธํ™”์— ๋„์›€์„ ์ค„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

EGCG๋Š” ๋…น์ฐจ์—์„œ ํ”ํžˆ ๋ฐœ๊ฒฌ๋˜๋Š” ํ”Œ๋ผ๋ณด๋…ธ์ด๋“œ์ž…๋‹ˆ๋‹ค. ์ˆ˜์„ธ๊ธฐ ๋™์•ˆ ๋‹ค์–‘ํ•œ ์ „ํ†ต ์˜ํ•™์—์„œ ๊ฑด๊ฐ• ์ฆ์ง„์„ ์œ„ํ•ด ํ™œ์šฉํ–ˆ์Šต๋‹ˆ๋‹ค. ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด EGCG๋Š” ํŠน์ • ์„ธ๋†€๋ฆฌํ‹ฑ ์ž‘์šฉ์„ ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํ•œ ์‹œํ—˜๊ด€ ์—ฐ๊ตฌ์—์„œ EGCG๋Š” ์ƒˆ๋กœ์šด ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„์˜ ์„ฑ์žฅ์„ ์ด‰์ง„ํ•˜์—ฌ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„์˜ ๊ธฐ๋Šฅ ์žฅ์•  ๊ฐœ์„ ์— ๋„์›€์ด ๋˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„๋Š” ์„ธํฌ์˜ ๋ฐœ์ „์†Œ์ž…๋‹ˆ๋‹ค. ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„๋Š” ์‹ ์ฒด ๊ธฐ๋Šฅ์— ํ•„์š”ํ•œ ์—๋„ˆ์ง€๋ฅผ ์ƒ์„ฑํ•ฉ๋‹ˆ๋‹ค.

๋‚˜์ด๊ฐ€ ๋“ค๋ฉด ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ธฐ๋Šฅ์ด ์ €ํ•˜๋˜์–ด ์—๋„ˆ์ง€๊ฐ€ ์ค„์–ด๋“ค๊ณ  ์‡ ์•ฝํ•ด์ง€๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Šต๋‹ˆ๋‹ค.

์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์—์„œ EGCG๋Š” ํ•ญ์‚ฐํ™” ์ž‘์šฉ์„ ํ•˜์—ฌ ๊ฑด๊ฐ•ํ•œ ๋…ธํ™”๋ฅผ ๋„์šธ ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ํ•œ ์‹œํ—˜๊ด€ ์—ฐ๊ตฌ์—์„œ๋Š” EGCG๊ฐ€ ์‚ฐํ™” ์ŠคํŠธ๋ ˆ์Šค๋ฅผ ์ค„์—ฌ ์žฅ์ˆ˜๋ฅผ ์ด‰์ง„ํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ์˜ ํ•ฉ์„ฑ์„ ๋Š˜๋ฆด ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค.

๋˜ํ•œ EGCG๋Š” ๊ฐ•๋ ฅํ•œ ํ•ญ์—ผ์ฆ ๋ฐ ํ•ญ์ข…์–‘ ์ž‘์šฉ๋„ ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ฒฐ๋ก 

์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋Š” ์ฒด๋‚ด ์ข€๋น„ ์„ธํฌ๋ฅผ ์ œ๊ฑฐํ•˜์—ฌ ๊ฑด๊ฐ•ํ•œ ๋…ธํ™”์— ๋„์›€์„ ์ค„ ์ˆ˜ ์žˆ๋Š” ๋†€๋ผ์šด ๋ถ„์ž์ž…๋‹ˆ๋‹ค. ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ๋งŽ์€ ์ฒœ์—ฐ ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๊ฐ€ ํ•ญ์—ผ์ฆ์ด๋‚˜ ํ•ญ์‚ฐํ™” ์—ญํ• ๊ณผ ๊ฐ™์€ ๋†€๋ผ์šด ํšจ๋Šฅ๋„ ๋ฐœํœ˜ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ฑด๊ฐ•ํ•œ ๋…ธํ™”๋ฅผ ๋ชฉํ‘œ๋กœ ํ•œ ๋ฃจํ‹ด์— ์„ธ๋†€๋ฆฌํ‹ฑ ๋ณด์ถฉ์ œ๋ฅผ ์ถ”๊ฐ€ํ•˜๋ฉด ์•ž์œผ๋กœ์˜ ์„ธ์›” ๋™์•ˆ ์žฅ์ˆ˜์™€ ์ตœ์ ์˜ ๊ฑด๊ฐ• ์ƒํƒœ์— ๋„์›€์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

์ฐธ๊ณ ๋ฌธํ—Œ:

  1. Steverson M. Ageing and health. World Health Organization. October 1, 2022. Accessed September 28, 2023. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
  2. Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-536. doi:10.1111/joim.13141
  3. Raffaele M, Vinciguerra M. The costs and benefits of senotherapeutics for human health. The Lancet Healthy Longevity. 2022;3(1). doi:10.1016/s2666-7568(21)00300-7
  4. Pal HC, Pearlman RL, Afaq F. Fisetin and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:213-244. doi:10.1007/978-3-319-41334-1_10
  5. Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. doi:10.1016/j.ebiom.2018.09.015
  6. LaTonya J. Hickson, Larissa G.P. Langhi Prata, Shane A. Bobart, Tamara K. Evans, Nino Giorgadze, Shahrukh K. Hashmi, Sandra M. Herrmann, Michael D. Jensen, Qingyi Jia, Kyra L. Jordan, Todd A. Kellogg, Sundeep Khosla, Daniel M. Koerber, Anthony B. Lagnado, Donna K. Lawson, Nathan K. LeBrasseur, Lilach O. Lerman, Kathleen M. McDonald, Travis J. McKenzie, Joรฃo F. Passos, Robert J. Pignolo, Tamar Pirtskhalava, Ishran M. Saadiq, Kalli K. Schaefer, Stephen C. Textor, Stella G. Victorelli, Tammie L. Volkman, Ailing Xue, Mark A. Wentworth, Erin O. Wissler Gerdes, Yi Zhu, Tamara Tchkonia, James L. Kirkland,Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease,EBioMedicine, Volume 47, 2019, Pages 446-456, ISSN 2352-3964, https://doi.org/10.1016/j.ebiom.2019.08.069. (https://www.sciencedirect.com/science/article/pii/S2352396419305912)
  7. Sun Y, Qin H, Zhang H, et al. Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells. Food Nutr Res. 2021;65:10.29219/fnr.v65.6355. Published 2021 Mar 25. doi:10.29219/fnr.v65.6355
  8. Shankar E, Goel A, Gupta K, Gupta S. Plant flavone apigenin: An emerging anticancer agent. Curr Pharmacol Rep. 2017;3(6):423-446. doi:10.1007/s40495-017-0113-2
  9. Perrott KM, Wiley CD, Desprez PY, Campisi J. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience. 2017;39(2):161-173. doi:10.1007/s11357-017-9970-1
  10. Chistiakov DA, Sobenin IA, Revin VV, Orekhov AN, Bobryshev YV. Mitochondrial aging and age-related dysfunction of mitochondria. Biomed Res Int. 2014;2014:238463. doi:10.1155/2014/238463
  11. Deledda A, Giordano E, Velluzzi F, et al. Mitochondrial Aging and Senolytic Natural Products with Protective Potential. Int J Mol Sci. 2022;23(24):16219. Published 2022 Dec 19. doi:10.3390/ijms232416219
  12. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12. doi:10.1016/j.mam.2008.08.006
  13. Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease [published correction appears in EBioMedicine. 2020 Feb;52:102595]. EBioMedicine. 2019;47:446-456. doi:10.1016/j.ebiom.2019.08.069
  14. Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-536. doi:10.1111/joim.13141
  15. LaTonya J. Hickson, Larissa G.P. Langhi Prata, et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease,EBioMedicine, Volume 47, 2019, Pages 446-456, ISSN 2352-3964, https://doi.org/10.1016/j.ebiom.2019.08.069. (https://www.sciencedirect.com/science/article/pii/S2352396419305912)
  16. Pal HC, Pearlman RL, Afaq F. Fisetin and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:213-244. doi:10.1007/978-3-319-41334-1_10
  17. Pan MH, Wu JC, Ho CT, Badmaev V. Effects of water extract of Curcuma longa (L.) roots on immunity and telomerase function. J Complement Integr Med. 2017;14(3):/j/jcim.2017.14.issue-3/jcim-2015-0107/jcim-2015-0107.xml. Published 2017 May 12. doi:10.1515/jcim-2015-0107
  18. Paredes-Gonzalez X., Fuentes F., Jeffery S., Saw C.L.L., Shu L., Su Z.Y., Kong A.N.T. Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin. Biopharm. Drug Dispos. 2015;36:440โ€“451. doi: 10.1002/bdd.1956.
  19. Perrott KM, Wiley CD, Desprez PY, Campisi J. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience. 2017;39(2):161-173. doi:10.1007/s11357-017-9970-1
  20. Raffaele M, Vinciguerra M. The costs and benefits of senotherapeutics for human health. The Lancet Healthy Longevity. 2022;3(1). doi:10.1016/s2666-7568(21)00300-7
  21. Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28-34. doi:10.1097/MCO.0b013e32834121b1
  22. Shankar E, Goel A, Gupta K, Gupta S. Plant flavone apigenin: An emerging anticancer agent. Curr Pharmacol Rep. 2017;3(6):423-446. doi:10.1007/s40495-017-0113-2
  23. Steverson M. Ageing and health. World Health Organization. October 1, 2022. Accessed September 28, 2023. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.
  24. Sun Y, Qin H, Zhang H, et al. Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells. Food Nutr Res. 2021;65:10.29219/fnr.v65.6355. Published 2021 Mar 25. doi:10.29219/fnr.v65.6355
  25. Tajmohammadi A, Razavi BM, Hosseinzadeh H. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review. Phytother Res. 2018;32(10):1933-1949. doi:10.1002/ptr.6153
  26. Woo J, Shin S, Cho E, et al. Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells. PLoS One. 2021;16(12):e0260545. Published 2021 Dec 16. doi:10.1371/journal.pone.0260545
  27. Xiong L.G., Chen Y.J., Tong J.W., Gong Y.S., Huang J.A., Liu Z.H. Epigallocatechin-3-Gallate Promotes Healthy Lifespan through Mitohormesis during Early-to-Mid Adulthood in Caenorhabditis Elegans. Redox Biol. 2018;14:305โ€“315. doi: 10.1016/j.redox.2017.09.019
  28. Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. doi:10.1016/j.ebiom.2018.09.015
  29. Zia A, Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S. The role of curcumin in aging and senescence: Molecular mechanisms. Biomed Pharmacother. 2021;134:111119. doi:10.1016/j.biopha.2020.111119